Amneal Pharmaceuticals
AMRX
AMRX
129 hedge funds and large institutions have $756M invested in Amneal Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
21% less funds holding
Funds holding: 164 → 129 (-35)
51% less capital invested
Capital invested by funds: $1.55B → $756M (-$789M)
57% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 58
Holders
129
Holding in Top 10
1
Calls
$875K
Puts
$476K
Top Buyers
| 1 | +$23.8M | |
| 2 | +$19.8M | |
| 3 | +$6.27M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.13M |
| 5 |
Millennium Management
New York
|
+$4.05M |
Top Sellers
| 1 | -$33.8M | |
| 2 | -$32.6M | |
| 3 | -$25.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.57M |